|
Able Energy, Inc.
Acorn Energy, Inc. (formerly Data Systems & Software Inc.)
Applied Neurosolutions, Inc.
Lpath, Inc.
Neurologix, Inc.
Oxis International, Inc.
Pharmos Corporation
Securac Corp.
Sono-Tek Corporation
TorreyPines Therapeutics, Inc.
Tower Semiconductor, Inc.
Acorn Energy, Inc. (formerly Data Systems & Software Inc.)
Applied Neurosolutions, Inc.
Lpath, Inc.
Neurologix, Inc.
Oxis International, Inc.
Pharmos Corporation
Securac Corp.
Sono-Tek Corporation
TorreyPines Therapeutics, Inc.
Tower Semiconductor, Inc.
|
Advanced Materials Design
- Preferred Stock investment and recapitalization
Applied Neurosolutions, Inc.
- $8 million PIPE of common stock, warrants
- $2.9 million PIPE of common stock warrants
Axonyx, Inc.
- $50 million PIPE transaction
- $20 million PIPE transaction
- Stockholder rights plan (poison pill)
Benedek Investments
- Investments in independent film projects
CDx Laboratories
- $10 million venture capital financing of preferred stock
Comverge Technologies, Inc.
- Acquisition of Scientific Atlanta's Control Systems Division
Acorn Energy, Inc. (formerly Data Systems & Software Inc.)
- $31 million sale of Israeli semiconductor foundry
- Several PIPE financings
- Acquisition of SCR Tech for $10 million
Dexmet Corporation
- Sale of privately held business
Digital Lava, Inc.
- $18 million initial public offering
Elbit Vision Systems, Ltd.
- $9.8 million registered offering of warrants, ordinary shares
- $13.4 million registered offering of ordinary shares
Espro Information Technologies Ltd
- Acquisition of Acoustiguide Inc.
Israel Berger & Associates
- Leveraged recapitalization
Life Medical Sciences
- $2.8 million private placement of preferred stock
Lpath, Inc.
- Reverse merger and PIPE financing
Medical Conferences International
- Sale of majority stake of privately held business in excess of
Mooney Aerospace, Inc.
- Privatization of public company
PEI Systems, Inc.
- Sale of privately held business
Plus Funds Group
- Recapitalization and preferred stock venture investment
Pharmos Corporation
- Acquisition of Vela Pharmaceuticals for cash and stock and related
- $50 million sale of opthalmic business
- $31 million underwritten common stock offering
- $16.75 million registered placement
- $21 million convertible debenture offering
- Numerous PIPE transactions of stock/debentures and warrants
- Stockholders rights plan (poison pill)
San Vicente Group
- Liquidation of Venture Capital Fund
Securac Corp.
- $10.5 million convertible debenture, equity line
The Equion Corporation
- Sales of automotive parts businesses
Tower Semiconductor, Inc.
- $73 million public offering of ordinary shares
- $50 million rights offering
United Rentals, Inc.
- $240 million public stock offering
- $1 billion senior note offerings
- $125 million convertible note offerings
Xtellus, Inc.
- Series A through D venture capital rounds
| PRINTER FRIENDLY |
